Intranasal dexmedetomidine sedation and analgesia during pediatric emergency room procedures
- Conditions
- Patients of the pediatric emergency room at Oulu University Hospital with any medical condition requiring a minor painful procedure such as i.v. cannulation or lumbar puncture are asked to join our study if they would seem to benefit from a sedative drug during the procedure.
- Registration Number
- 2024-518816-38-00
- Lead Sponsor
- Oulu University Hospital
- Brief Summary
Our objective is to determine if intranasal dexmedetomidine is a safe and effective sedative drug during small painful procedures in the pediatric emergency room.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised, recruitment pending
- Sex
- Not specified
- Target Recruitment
- 112
Age 1-12 years
Small procedure (e.g. i.v. cannulation or lumbar puncture)
Presents at the Oulu University Hospital emergency room
Allergy to dexmedetomidine or any supplementary elements of the dexmedetomidine-solution
II or III degree AV-blockage without pacemaker
Uncontrollable hypotension
Stroke
Critically ill patients who are admitted to the Pediatric Intensive Care Unit
Patients with clear cardiac or respiratory dysfunction
Lowered level of consciousness
Patients with increased risk of apnoeic events due to neurologic or metabolic conditions or extreme obesity
Prior participation to the current study
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary end point(s): The primary end point in this study is the success of the procedure at the first attempt.;Timepoint(s) of evaluation of this end point: The success rate of the first attempt of the procedure is evaluated at the end of the first attempt of the procdure.;Main Objective: Our objective is to determine if intranasal dexmedetomidine is a safe and effective sedative drug during small painful procedures in the pediatric emergency room. ;Secondary Objective: The duration of sedative effects of 1µg/kg intranasal dexmedetomidine spray is assessed. The success of the procedure at the first attempt The success of the procedure at the first attempt
- Secondary Outcome Measures
Name Time Method The duration of the procedure The duration of the procedure
Parents assessment of the patients comfortability during the procedure Parents assessment of the patients comfortability during the procedure
Patient's and physician's assessment of the experienced pain with Visual Analog Scale Patient's and physician's assessment of the experienced pain with Visual Analog Scale
Assessment of pain levels of the patient with FLACC-scores Assessment of pain levels of the patient with FLACC-scores
Assessment of sedation levels of the patient with Comfort-B-scores Assessment of sedation levels of the patient with Comfort-B-scores
Duration of crying Duration of crying
The parents and the emergency room nurses are asked whether they think the patient recieved the experimental drug or placebo The parents and the emergency room nurses are asked whether they think the patient recieved the experimental drug or placebo
Blood pressure measured by manometer Blood pressure measured by manometer
Respiratory rate assessed by capnometry Respiratory rate assessed by capnometry
Oxygen saturation is measured by pulse oxymetry Oxygen saturation is measured by pulse oxymetry
Heart rate measured by ECG Heart rate measured by ECG
Trial Locations
- Locations (1)
Oulu University Hospital
🇫🇮Oulu, Finland
Oulu University Hospital🇫🇮Oulu, FinlandOuti PeltoniemiSite contact+35883155837outi.peltoniemi-ailisto@pohde.fi